期刊文献+

肠道病毒71 VP1基因的原核表达及其抗血清的制备 被引量:5

The expression of EV71 VP1 gene and preparation of its antiserum
下载PDF
导出
摘要 目的克隆并表达重组肠道病毒71(EV71)VP1基因,进行抗血清的制备并检测抗血清效价。方法利用原核表达系统将PCR获得的VP1片段构建成原核表达载体pET32a(+)-VP1,诱导其表达VP1融合蛋白并利用包涵体纯化方法进行重组蛋白的纯化,将纯化的重组蛋白免疫新西兰兔制备VP1抗血清,ELISA检测抗体效价。同时构建真核表达载体,利用其在真核细胞中的瞬时表达检测抗血清的特异性。结果通过克隆获得VP1原核表达载体,IPTG诱导VP1蛋白表达并纯化,SDS-PAGE结果显示重组蛋白表达且纯化浓度较高,将重组蛋白乳化后免疫新西兰兔3次,取血检测抗血清的效价,ELISA结果显示抗体效价为1∶64 000,利用所构建真核表达载体pcDNA3.1(+)-VP1表达VP1对抗血清进行检测,Western blot结果表明抗血清可较好的与VP1特异性结合。结论制备具有免疫原性的VP1蛋白及其效价较高的抗血清,为进一步研究抗EV71诊断方法、血清学诊断试剂盒及抗病毒疫苗的研制奠定基础。 EV71 is a main virus of hand-foot-moth disease, while VP1 has main antigenic determinant of EVT1. In this study, we aimed to prepare VP1 antiserum and detect its titer by cloning and expressing recombinant VP1 gene. Firstly, the prokaryotic expression vector pET32a (+)-VP1 was constructed by using VP1 fragment from PCR product, and the recombinant protein expressed. Then the purified recombinant protein was used to immunize New Zealand rabbits for preparing VP1 antiserum. At the same time, a eukaryotic expression vector of VP1 was constructed with the aim of detecting the antiserum specificity. ELISA revealed that antibody titer of the prepared antiserum was 1:64 000; Western blot test of eukaryotic expression vector pcDNA3.1 (+)-VP1 protein showed that the antiserum could specifically bind with VP1. Preparation of immunogenic VP1 protein and high titer antiserum has laid a foundation for further study on the methods of diagnosis and resistance vaccine.
出处 《免疫学杂志》 CAS CSCD 北大核心 2013年第1期38-42,共5页 Immunological Journal
基金 国家自然科学基金(31272586) 国家转基因重大专项(2009ZX08007-006B 2011ZX08007-002 2011ZX08008-004) 山东省青年自然科学基金项目(ZR2010ZR029) 山东省自然科学基金(ZR2010CM012) 济南市高校院所主创新计划(201004027)
关键词 肠道病毒71 VP1 抗血清 抗体效价 Enterovirus 71 VP1 Antiserum Antibody titer
  • 相关文献

参考文献4

二级参考文献22

  • 1徐平,谢鹏,邹德智,左联.中国精神病人外周血博尔纳病病毒P24基因片段检测[J].中国人兽共患病杂志,2004,20(6):471-473. 被引量:7
  • 2徐平,谢鹏,邹德智.博尔纳病病毒与慢性格林-巴利综合征[J].中华微生物学和免疫学杂志,2004,24(6):425-425. 被引量:6
  • 3王振海,谢鹏,杨平,孔繁元.病毒性脑炎患者血液和脑脊液博尔纳病病毒p24的检测[J].中华神经科杂志,2006,39(2):105-108. 被引量:15
  • 4Lin TY,Chang LY, Hsia SH, et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002,34 Suppl 2 : S52-57.
  • 5McMinn P, Lindsay K, Perera D, et al. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol,2001, 75(16) :7732-7738.
  • 6Shih SR,Ho MS, Lin KH,et al. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot, and mouth disease during an epidemic in Taiwan, 1998. Virus Res, 2000,68 (2) : 127-136.
  • 7Brown BA, Oberste MS, Alexander JP Jr, et al. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Wirol, 1999,73(12) :9969-9975.
  • 8Yu-Chen Hu,John Tsu-An Hsu,Jen-Huang Huang,Mei-Shang Ho,Yi-Chen Ho.Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells[J].Biotechnology Letters.2003(12)
  • 9Yu-Chen Hu,Hung-Jen Liu,Yao-Chi Chung.High level expression of the key antigenic protein, σC, from avian reovirus into insect cells and its purification by immobilized metal affinity chromatography[J].Biotechnology Letters.2002(12)
  • 10Sarah C. Gilbert.Virus-like particles as vaccine adjuvants[J].Molecular Biotechnology.2001(2)

共引文献60

同被引文献68

  • 1林思恩,章青,谢华萍,谢健萍,何家鑫,董巧丽,方肇寅.我国广东、福建地区2000~2001年手足口病肠道病毒71型分离株的种系进化分析[J].中华实验和临床病毒学杂志,2004,18(3):227-229. 被引量:108
  • 2凌明圣,许祥裕,丁树标.以包涵体形式存在的重组蛋白的纯化和体外折叠[J].中国生化药物杂志,1995,16(3):135-139. 被引量:13
  • 3罗惠霞,李敏,王玉炯.包涵体蛋白复性的几种方法[J].生物技术通报,2007,23(5):96-98. 被引量:25
  • 4Tan E L,Tan T M,Chow V T,et al. Enhanced potency and ef- ficacy of 29-mer shRNAs in inhibition of Enterovirus71 [J]. Antiviral Res, 2007,74 : 9-15.
  • 5Zhu Z,Zhu S L, Guo X B, et al. Retropective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large- scale outbreaks from 2008[J]. Virol J, 2010,7 : 300.
  • 6Muir P, Kammerer U, Korn K, et al. Molecular typing of en- teroviruses: current status and future requirements [J]. Clin Microbial Rev, 1998,11 (1) :202-227.
  • 7Yu N,Guo M,He S J,et al. Evaluation of human enterovirus 71 and coxsackievirus A16 specific immunoglobulin M anti- bodies for diagnosis of hand-foot-and-mouth disease[J]. Virol J,2012,9:12-18.
  • 8Word Health Organization. WHO GlohaI Task Force on TB Impact Measurement-information leaflet[EB/OL]. (2013-4- 15 ) [2013 - 10 -20].http://www.who.int/th/publieations/ faetsheet_th_impactnleasurement.pdf?ua= 1.
  • 9Rawlings ND, Barrett AJ, Bateman A. MEROPS: the database of proteolytie Enzymes, their substrates anti inhibitors[J]. Nucleic Acids Res. 2013, 41 (1): 503-509.
  • 10Porankiewicz J.Wang J,Clarke AK. New insights into the ATP-dependent Clp protease: Escherichia coli and beyond[J]. Mol Microbiol, 1999, 32(3): 449-458.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部